ReviewNature reviews. Clinical oncology2026

Reconsidering adjuvant and perioperative immune-checkpoint inhibition: de-escalation, expansion and personalization.

Douglas B Johnson et al.PubMed ↗Publisher ↗

No numbers read from the abstract.